AGM-130 is a selective cyclin-dependent kinase (CDK) inhibitor that interferes with cell cycle progression. It has demonstrated significant antitumor activity, making it a valuable tool for cancer research. This compound can be utilized in studies aimed at understanding CDK modulation and its potential therapeutic implications in oncology.
AGM-130 is a selective cyclin-dependent kinase (CDK) inhibitor that interferes with cell cycle progression. It has demonstrated significant antitumor activity, making it a valuable tool for cancer research. This compound can be utilized in studies aimed at understanding CDK modulation and its potential therapeutic implications in oncology.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
